Patient Information Leaflet
Desloratadina ratiopharm 5mg Film-Coated Tablets
desloratadina
For adults
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow exactly the administration instructions contained in this leaflet or those given by your doctor or pharmacist.
1.What is Desloratadina ratiopharm and what it is used for
2.What you need to know before taking Desloratadina ratiopharm
3.How to take Desloratadina ratiopharm
4.Possible side effects
5.Storage of Desloratadina ratiopharm
6.Contents of the pack and additional information
What is Desloratadina ratiopharm
Desloratadina ratiopharm contains desloratadine, which is an antihistamine.
How Desloratadina ratiopharm works
Desloratadina ratiopharm is an antiallergic medication that does not cause drowsiness. It helps control the allergic reaction and its symptoms.
When to use Desloratadina ratiopharm
Desloratadina ratiopharm relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or dust mite allergy) in adults. These symptoms include sneezing, runny nose or nasal itching, palate itching, eye redness or tearing.
Desloratadina ratiopharm is also used to relieve symptoms associated with chronic idiopathic urticaria (skin disease of unknown cause), diagnosed initially by your doctor. These symptoms include itching and skin hives.
The relief of these symptoms lasts a full day and helps you continue your daily activities and normal sleep periods.
You should consult a doctor if it worsens or does not improve after 7 days. If you notice difficulty breathing or swelling of the lips, tongue, or throat, you should consult a doctor immediately.
Do not takeDesloratadina ratiopharm
-if you are allergic to desloratadina, loratadinaor any of the other ingredients of this medication (listed in section6).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Desloratadina ratiopharm:
If you have chronic idiopathic urticaria, it must be diagnosed by your doctor before starting to take Desloratadina ratiopharm.
Children and adolescents
Do not administer this medication toadolescents andchildren under 18years of age.
Other medications andDesloratadina ratiopharm
Inform your doctor or pharmacist if you are taking, have taken recently or may have to take any other medication.
No known interactions have been reported betweenDesloratadina ratiopharmand other medications.
TakingDesloratadina ratiopharmwith food, drinks and alcohol
Desloratadina ratiopharmcan be taken regardless of meals.
Be careful when taking Desloratadina ratiopharm with alcohol.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or intend to become pregnant, consult your doctor or pharmacist before using this medication.
It is not recommended to takeDesloratadina ratiopharmif you are pregnant.
Your doctor will decide whether to interrupt breastfeeding or interrupt treatment with Desloratadina ratiopharm.
No data is available on male and female fertility.
Driving and operating machinery
At the recommended dose, it is not expected that this medication will affect your ability to drive or operate machinery. Although most people do not experience drowsiness, it is recommended not to perform activities that require a state of mental alertness, such as driving a car or operating machinery, until you have determined your own response to the medication.
Desloratadina ratiopharmcontains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
This medication contains less than 1mmol of sodium (23mg) per tablet; this is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is one tablet once a day with water.
The tablet can be taken with or without food.Swallow the tablet whole.
The duration of treatment depends on the type, duration, and evolution of symptoms.You should consult a doctor if symptoms worsen or do not improve after 7 days.If you notice difficulty breathing or swelling of the lips, tongue, or throat, you should consult a doctor immediately.
If your allergic rhinitis symptoms used to last less than 4 days a week or less than 4 weeks, use this medication until symptoms have disappeared.You can start using this medication again when symptoms reappear.
If your allergic symptoms used to last longer (4 or more days a week and for more than 4 weeks), continuous treatment during the exposure period to the allergen may be necessary.
For chronic idiopathic urticaria, treatment may be necessary for more than 6 weeks, depending on your symptoms.If symptoms reappear after interrupting treatment, you can take this medication again.
If you take more Desloratadina ratiopharm than you should
No serious problems are expected from an accidental overdose. However, if you take more Desloratadina ratiopharm than you should, tell your doctor or pharmacist immediately.
If you forgot to take Desloratadina ratiopharm
If you forgot to take your dose at the usual time, take it as soon as possible and then continue with your usual dosing schedule.Do not take a double dose to make up for the missed dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not everyone will experience them.
The following adverse effects are very rare, but you must stop taking this medication and seek urgent medical attention immediately if you notice them:
Other Adverse Effectsthat may occur are:
Frequent (may affect up to 1 in 10people)
Very Rare(may affect up to 1 in 10,000people)
Unknown Frequency(cannot be estimated from available data)
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the national notification system included in theAppendixV. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and blister after EXP.The expiration date is the last day of the month indicated.
Do not store above 86°F (30°C).
Store in the original packaging to protect it from moisture.
Do not use this medication if you observe any change in the appearance of the tablets.
Medications should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medications that you no longer need. In this way, you will help protect the environment.
Composition ofDesloratadina ratiopharm
Core tablet: poloxamer type 188, citric acid monohydrate, microcrystalline cellulose, cornstarch, lactose monohydrate (see section2 “Desloratadina ratiopharm contains lactose and sodium”, talc.
Covering: partially hydrolyzed polyvinyl alcohol, titanium dioxide (E171), macrogol/PEG 3350, talc, andaluminum lacquer with indigo carmine blue (E132).
Appearance of the product and contents of the package
Round, biconvex, blue film-coated tablets.
Desloratadina ratiopharm5mg film-coated tablets are available in blister packs of PVC/PVdC/aluminum of7, 10, 14, 15, 20, and 30 film-coated tablets.
Only some package sizes may be marketed.
Holder of the marketing authorization
ratiopharm GmbH
Graf-Arco-Straße 3
89079 Ulm
Germany
Responsible for manufacturing
Merckle GmbH
Ludwig-Merckle-Straße 3
89143 Blaubeuren
Germany
or
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13,
4042 Debrecen,
Hungary
or
Pharmachemie B.V.
Swensweg 5, 2031 GA Haarlem
Netherlands
or
Teva Czech Industries s.r.o
Ostravska 29, c.p. 305, 74770
Opava-Komarov
Czech Republic
or
Teva Operations Poland Sp. Z o.o.
ul. Mogilska 80. 31-546
Krakow
Poland
For more information about this medicine, please contact the local representative of the marketing authorization holder:
België/Belgique/Belgien Teva Pharma Belgium N.V. /S.A./AG Tel/Tel: +32 3 820 73 73 | Lietuva UABTeva Baltics Tel: +370 5 266 0203 | |
???????? ???? ???????? ???.: +359 24899585 | Luxembourg/Luxemburg ratiopharm GmbH Allemagne/Deutschland Tél/Tel:+49 731 402 02 | |
Ceská republika Teva Pharmaceuticals CR, s.r.o. Tel: +420 251 007 111 | Magyarország Teva Gyógyszergyár Zrt. Tel: +361288 64 00 | |
Danmark Teva Denmark A/S Tlf.: +45 44 98 55 11 | Malta Teva Pharmaceuticals Ireland, L‑Irlanda Tel: +35319127700 | |
Deutschland ratiopharm GmbH Tel:+49 731 402 02 | Nederland Teva Nederland B.V. Tel.: +31 800 0228400 | |
Eesti UABTeva BalticsEesti filiaal Tel:+372 661 0801 | Norge Teva Norway AS Tlf: +47 66 77 55 90 | |
Ελλ?δα SpecifarΑ.B.E.Ε. Τηλ: +30 2118805000 | Österreich ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1 97 0070 | |
España Teva Pharma, S.L.U. Tel: +34913873280 | Polska Teva Pharmaceuticals Polska Sp.z.o.o Tel: +48 22 345 93 00 | |
France Teva Santé Tél: +33 155917800 | Portugal ratiopharm, Comércio e Industria de Produtos Farmacêuticos Lda Tel: +351 21476 75 50 | |
Hrvatska Pliva Hrvatska d.o.o. Tel: +385 1 37 20 000 | România Teva Pharmaceuticals S.R.L Tel: +40 21 230 65 24 | |
Ireland Teva Pharmaceuticals Ireland Tel: +35319630330 | Slovenija Pliva Ljubljana d.o.o. Tel: +386 1 58 90 390 | |
Ísland Teva Pharma Iceland ehf. Sími:+3545503300 | Slovenská republika TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 2 57 267 911 | |
Italia Teva Italia S.r.l. Tel: +39 02 8917981 | Suomi/Finland Teva Finland Oy Puh/Tel: +358 20 180 5900 | |
Κ?προς SpecifarΑ.B.E.Ε. Ελλ?δα Τηλ: +30 2118805000 | Sverige Teva Sweden AB Tel: +46 42 12 11 00 | |
Latvija UABTeva Balticsfiliale Latvija Tel: +371 673 23 666 | United Kingdom Teva UK Limited Tel: +441977 628500 |
Last review date of this leaflet:
The detailed information on this medicine is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.